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Brief Definitive Report 
TUMOR-PROMOTING  PHORBOL  ESTERS  SELECTIVELY 
ABROGATE  THE  EXPRESSION  OF  THE 
T4  DIFFERENTIATION  ANTIGEN  EXPRESSED  ON  NORMAL 
MALIGNANT  (SI),ZARY)  T  HELPER  AND  LYMPHOCYTES* 
BY  WERNER  SOLBACH 
From the Institut fh} Medizinische  Mikrobiologie der Johannes  Gutenberg-  Universita'l, Hochhaus am 
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One  of  the  most  active  tumor-promoting  reagents  is  the  phorbol  ester  12-O- 
tetradecanoylphorbol  13-acetate  (TPA),  initially  isolated  from  croton  oil  (3).  This 
compound  induces  various  biological  and  biochemical  effects  on  cultured  cells, 
including  lymphocytes  (4  11). We  and  others  have  observed  that  TPA  is  able  to 
induce  certain  human  (12)  and  murine  (8)  leukemic T  cells  to  secrete a  variety of 
lymphokines, including the T  cell growth factor interleukin  2 (II-2). 
As  a  number of reports  (8  10)  describe  the  ability of TPA  to  modulate  the  cell 
surface profile of a variety of myeloid or lymphocytic cells, we screened the phenotype 
of normal and  S6zary peripheral blood lymphocytes (PBL)  under conditions  shown 
previously to induce I1-2 production.  During these studies, we realized that in normal 
as  well  as  in  malignant  T  cell  populations  the  T4  differentiation  antigen  had 
disappeared  selectively, whereas  the  T  cell  markers,  as  defined  by the  monoclonal 
antibodies  anti-T3,  -T6,  -T8,  -T11,  the  Ia alloantigen  present  on  B  cells,  null  cells, 
monocytes,  and  activated  T  cells  (19),  and  cell  surface  Ig  on  B  cells,  were  still 
detectable. 
Furthermore, we investigated whether there exists a correlation between the chem- 
ical  structure  of phorbol  and  some  of its  esters  and  the  capacity  to  abrogate  the 
expression of the T4 antigen.  From the compounds tested  (TPA, 4,8-phorbol-12-13- 
didecanoate  [4fl-PDD],  4a-phorbol-12,13-didecanoate  [4a-PDD],  and  phorbol,  the 
mother compound),  we  found  that  only those  with  tumor-promoting activity  (i.e., 
TPA and 4fl-PDD) cause abrogation of the T4-antigen, whereas the agents 4~-PDD 
and phorbol, known to be inactive in tumor promotion, fail to do so. 
Materials and Methods 
Culture Medium.  Cells were cuhured in RPMI  1640 culture medium supplemented with  10 
mM ttepes buffer, 2 mM L-glutamin, 0.15(~ NattCO;3, antibiotics, 5 X  10  '~ M  2-mercaptoeth- 
anol, and 2  10% heat-inactivated fetal calf serum (all obtained from Gibco Laboratories, (;-rand 
Island Biological Co., Grand Island, NY). 
Cells.  PBL were obtained from either healthy donors or from a  patient with the confirmed 
clinical diagnosis of S6zary syndrome after density gradient centrifugation using Ficoll-t typaque 
(y  =  1,078  g/cma).  T4-positive  cells  were  obtained  by  enrichment  for  T  cells  by  E-rosette 
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TABLE  I 
Effect  of TPA on 11-2 Production by Normal and Malignant  T4-positive  Helper Cells 
1251 
T cells from 
Surface profile (percent- 
age positive  cells before 
culture) 
11-2 activity in the supernatants ofT cells activated with 
T4  T8  T11  TPA  PHA  TPA plus PHA  Medium 
Sfizary syndrome  99  0  99  2786 ++. 381"  400 ±  74  5423 ± 453  273 ±  72 
Normal  93  3  96  382 ± 206  950 :t: 250  6023 ± 782  285 ±  135 
1 x  106 cells/ml T4-positive  PBL from a patient with S~zary syndrome or normal donors obtained by methods described 
in detail previously (13) were incubated in the presence of TPA (10 ng/ml), PHA (0.5 p.g/ml), or both for 24 h at 37°C. 
The surface profile  of the cells before  culture was determined by indirect immunofluorescence. 
* Incorporation of [aH]thymidine by 2.5 × 10  a 11-2-dependent Tn cells after 48 h of culture in the presence of 25% (vol/ 
vol) culture supernatants obtained from activated normal or Sfizary T cells (cpm --. SD from six replicates). 
depletion and  subsequent  complement-dependent  negative selection procedures,  as described 
in detail previously (12).  Cells were cultured in a water-saturated atmosphere at 37°C, 5% CO2. 
Surface Marker Analysis.  Cell surface markers were determined using monoclonal mouse anti- 
human  antibodies  (final  dilution,  1:1,000)  and  goat  anti-mouse  immunoglobulin-fluorescein 
isothiocyanate  (Ig-FITC)-coupled F(ab')2 fragments as second antibody  (final dilution,  1:20). 
Surface Ig was detected  by using goat anti-human  Ig-FITC-coupled F(ab')2  fragments  (final 
dilution,  1:20).  All  incubations  were  done  for  45  rain  at  4°C.  Percentage  of cells showing 
inmmnofluorescence was determined microscopically. 
Antibodies.  Antibodies were obtained as follows. Anti-OKT3 (Ortho Pharmaceutical,  Rari- 
tan,  NJ);  anti-Ia  (NEN,  Dreieich,  FRG);  goat  anti-human  or  mouse  Ig-FITC  (Tago,  Bur- 
lingham, CA); and anti-T4,  -T6, -T8, -T11  antibodies were a  kind gift of Dr.  Ellis Reinherz, 
Sidney Farber Cancer Institute, Boston, MA. 
Inducing Agents.  The cells were incubated  for various periods of time in the presence of the 
following compounds  (Sigma  Chemical  Co.,  Munich,  FRG):  PHA  (Wellcome, Beckenham, 
EngIand); Phorbol, P8893 mol wt, 364.4; 4a-PDD, P8014, moI wt, 620.6; 4fl-PDD, P9018, mol 
wt, 620.6; TPA, P8139,  mol wt, 618.8.  Phorbol and its esters were dissolved as stock solutions 
(1 mg/ml) in 96% ethanol and stored at -70°C  until use. 
Production of and Assay  for Il-2 Activity.  1 ×  106 cells/ml T4-positive cells, obtained as described 
in detail previously (13), were incubated in the presence of TPA (10 ng/ml), PHA (0.5/~g/ml), 
or both for 24 h  at 37°C. The culture supernatants  were harvested and tested for I1-2 activity 
by  their  ability to  maintain  growth  of the  murine  I1-2-dependent  cell line Tm  (gift of Dr. 
Thomas Hiinig, Institute for Virology, University of Wiirzburg, FRG). 2.5 ×  103 Tn cells were 
incubated in 200/.d culture medium containing 25% (vol/vol) of the supernatants  to be tested 
in microtiter plates for 48 h.  During the last 8  h  of the culture,  the cells were pulsed with 0.5 
#Ci  [3H]thymidine.  The cultures  were then  harvested,  and  [3H]tbymidine  incorporation  was 
counted.  TPA,  PHA, and  the combination of both  by themselves did  not  influence the II-2- 
mediated proliferation of TH cells. 
Results  and  Discussion 
Table  I  shows  that  TPA  causes  the  secretion  of 11-2  by  human  leukemic  T  cells 
from  a  patient  with  S~zary  syndrome,  expressing  the  T4 +,  T8-,  T11 +  cell  surface 
phenotype.  This surface phenotype  has been shown  to be characteristic  for human  T 
helper cells  (1),  including the II-2 producer  cells (12).  In contrast,  in  peripheral  T4 +, 
T8-,  T11 +  lymphocytes  from  normal  donors,  TPA  itself causes  no  significant  II-2 
production,  but  acts synergistically in  the  PHA-mediated  activation of I1-2 producer 
cells, possibly by substituting  for the macrophage  product  11-1  (13).  If the cell surface 
phenotype of such cells is analyzed after  18 h  of culture, TPA  causes both normal and 
malignant  (S~zary)  T  lymphocytes  to convert  from T4-positivite to T4-negative cells 
(Table II). The expression of the T  cell antigens T3, T6, T8, T11,  the Ia-antigen, and 
surface Ig-bearing B  cells is not affected. 1252  WERNER  SOLBACH  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Effect of TPA on Cell Surface Markers 
Antibody  Reacts with (reference) 
Normal  PBL cultured  S~zary PBL cultured 
for  18 h  in  for 18 h  in 
TPA 
Medium  (10 ng/ 
ml) 
Medium  TPA 
Anti-OKT3  All T  cells  (1)  63*  65  99  99 
Anti-T4  Mature inducer (helper)  T  cells  (1)  42  0  97  0 
Anti-T6  Stage II thymocytes (16,  17)  2  2  0  0 
Anti-T8  Mature cytotoxic/suppressor  T  cells  23  25  0  0 
(1) 
Anti-Tl I  All SRBC-positive (T) cells (18)  67  67  99  99 
Anti-la  B cells, null  cells, monocytes,  28  27  0  0 
activated T  cells  (19) 
Anti-human  Ig  B cells (20)  25  25  0  0 
1 x  10  a cells/m[  normal  or S~zary-PBL were cultured  for  18 h  at  37°C in the presence or absence of TPA  (10 ng/ml). 
After culture,  they were washed vigorously, and surface marker analysis was done  using the antibodies as listed on the 
left. 
* Denotes percent of positive cells in indirect immunofiuorescence;  mean of seven experiments. 
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Flo.  1.  Panel A:  1 X  106 cells/ml normal (0) or S~zary-PBL (A) were incubated in the presence 
of TPA in the concentrations, as indicated, for 18 h at 37°C. The number of T4-positive cells was 
then determined in indirect immunofluorescence and compared to the number of T4-positive cells 
incubated without TPA  (42% of all normal PBL and 99% of all S~zary-PBL).  Panel B:  1 ×  106 
cells/ml normal or S~zary-PBL were incubated in the presence of 5 ng/ml TPA at 37°C or at 4°C 
for the times as indicated on the abscissa. The number of T4-positive cells was then determined and 
compared with the number of T4-positive cells incubated without TPA.  (0) normal PBL, 37°C; 
(&) S~zary-PBL, 37°C; (O) normal PBL, 4°C, (A) S~zary-PBL, 4°C. In all experiments, the T8 and 
T11 markers were determined simultaneously without any significant change of the percentage of 
positive cells (data not given). 
The  data  in Fig.  1 (left panel)  demonstrate  that the abrogation  of the expression of 
the T4 marker  occurs at a  TPA  concentration  as low as 0.6 ng/ml  and  is complete  at 
2.5 ng/ml.  Furthermore,  Fig.  1  (right panel)  shows that  this process requires time, as 
50% of the initially T4-positive cells are T4  negative after ~4.5  h  incubation  time at 
37°C  and are completely negative after 8  h.  Moreover,  the T4  marker  disappearance 
occurs only at 37°C  but  not  at  4°C  (Fig.  1).  The  data  in Table  III show  that  the T4 WERNER  SOLBACH  BRIEF  DEFINITIVE  REPORT  1253 
TABLE  III 
TPA Effect  on T Cells Is Reversible 
TPA  Medium  Medium  Medium 
Medium  (5 ng/ml)  (wash 3X)  (wash 3X)  (wash 3X) 
Time  0 h  18 h  42 h  66 h  138 h 
Normal PBL  , T4  42*  0  0  0  48~: 
Normal§ PBL  Tl 1  67  69  69  70  68 
S~.zary PBL  T4  98  0  0  0  99 
SSzary§ PBL  T11  99  99  99  99  99 
0.5 X  l0  s cells/ml normal or Sgzary-PBL were pulsed for 18 h with 5 ng/ml TPA. Cells were then washed three times 
and kept in culture medium (5% fetal calf serum), which was replaced by fresh medium after repeated washings and 
readjustment of the cell concentration to 0.5 X  10  n cells/ml after 42 and 66 h. At the time points indicated, percentage 
of T4- and Tl 1-positive cells was determined. 
* Denotes percent of positive  cells in immunofluorescence. 
The cells did not express  the T4 antigen 138 h after onset  of the culture when they were reexposed  to TPA (5 ng/ml) 
after the washing procedures at  18, 42, and 66 h, respectively. 
§ Cells not pulsed with TPA did not change antigen profile  during culture. 
TABLE  IV 
Effect of Phorbol andDifferent Esters on Cells Surface Markers 
Compound (10 ng/ml) 
Expression  of antigen 
T4  T11 
Tumor-promoting 
activity in VlVO 
Phorbol  99 (40)*  99 (68)  -- 
4a-phorbol- 12,13-didecanoate  99 (40)  99 (68)  -- 
4fl-phorbol-12,13-didecanoate  39 (19)  98 (68)  +++ 
12-O-tetradecanoylphorbol  0  (0)  99 (71)  ++++ 
13-acetate  (TPA) 
1 ×  l0  s cells/ml S~zary-PBL or normal PBL (values in brackets)  were incubated for 18 h in the presence of 10 ng/ml of 
the compounds phorbol, 4ct-PDD,  4fl-PDD, or TFA. After vigorous washings the percentage of T4- and Tl I-positive 
cells was determined. In the right part of Table IV, the relative tumor promotion activity on mouse skin of the agents 
used  is listed  (according to Diamond et al.  (2)). 
* Values represent percent of positive cells in immunofluorescence (mean of seven experiments). 
disappearance is reversible. Thus, when PBL were pulsed for 18 h  with TPA, then 
washed  repeatedly  every  24  h,  the  T4  marker  expectedly  disappeared  initially. 
However, between 66 and 138 h after onset of the cultures, a complete T4 reexpression 
was observed. The nature of the T4-positive target cells seems to be irrelevant, as not 
only cells from normal or leukemic donors, but also the leukemic T  cell lines MOLT4 
and JURKAT respond similarly under the influence of TPA (data not given). This 
finding is in good agreement with Delia et al. (9), who described similar observations 
using T-ALL cell lines. 
In  a  number of systems,  a  rigid  relationship  between  the  chemical  structure of 
phorbol and its esters and a  variety of biological effects has been described (2).  We, 
therefore, investigated the effect of TPA, 4fl-PDD, 4a-PDD, and phorbol itself on the 
expression of the T4 antigen. Table IV shows that only the tumor-promoting agents 
(i.e.,  TPA and  4fl-PDD)  cause abrogation  of the T4-antigen  expression, while 4a- 
PDD and phorbol fail to do so. 
One interpretation of our results would be that  TPA and  4fl-PDD modulate the 
cellular  binding  site  recognized  by  the  anti-T4-antibody,  thus  decreasing  the  net 
binding affinity. This type of mechanism  has been reported for the TPA-mediated 
decrease in binding of epidermal growth factor (14). Alternatively, tumor-promoting 
phorbol esters may decrease the number of anti-T4 antibody-binding sites by shedding 
mechanisms or internalization and subsequent  degradation of the relevant binding 1254  WERNER SOLBACH  BRIEF  DEFINITIVE REPORT 
components.  Removal  of TPA  from  the  system  would  lead  to synthesis  of new  T4 
molecules. This argument  is favored by the finding that  48  120  h  were required  for 
the T4  marker  to reappear  after an  18-h TPA pulse,  despite  repeated  and  vigorous 
washings of the cells.  However, it has to be taken  into consideration  that, because of 
the highly lipophilic nature of TPA, it  might be difficult to remove TPA completely. 
Only  tumor-promoting  phorbol  esters,  but  not  inactive  compounds,  seIectiveIy 
affect the expression of the T4 antigen on T  lymphocytes (Table I, ref. 2). This finding 
suggests that selective, yet unknown TPA-mediated modulations in anti-T4 antibody 
interaction  with  its binding site  may be related  to the mechanisms  by which  tumor 
promoters  affect  the  growth  pattern  of normal  or  malignant  cells.  It  can  now  be 
studied,  inasmuch  as  the  T4  antigen  on  T  lymphocytes is  required  for the  cells  to 
exert  immune  functions.  For  example,  T4-positive  T  cells  produce  a  variety  of 
lymphokines (I, 21), including I1-2 (12). Under the conditions used in the experiments 
in Table I, TPA-induced II-2 production in Sfizary T  cells reaches its maximum after 
24  h.  However,  the  II-2 producer  cells  are  already  T4  negative  after  8  h  in  culture 
(Fig.  1).  Thus,  it  appears  that  there  exists  no  stringent  correlation  between  the 
expression of the T4 antigen and the ability to function as an II-2-producing T  helper 
cell. 
Summary 
12-O-tetradecanoylphorbol-13-acetate  (TPA)  selectively  abrogates,  in  nanomolar 
concentrations,  the  expression  of the  T4  differentiation  antigen,  as  defined  by  the 
monoclonal  anti-T4  antibody  (1)  on  I1-2-producing  T  helper  lymphocytes  from 
normal  donors and  on T  helper  lymphocytes from a  patient  with  malignant  T  cell 
lymphoma (S~zary's syndrome); this compound does not affect the expression of cell 
surface antigens as defined by the antibodies  anti-OKT3, -T6, -TS, -T11, Ia, or anti- 
surface  immunoglobulin.  Abrogation  of the  T4  antigen  expression  is  concentration 
dependent,  completed within 8  h  of incubation  at  37°C, does not occur at  4°C, and 
is  reversible.  Only those  phorbol-esters  known  to  have  tumor-promoting activity  in 
vivo (2)  affect the T4 antigen, whereas nonpromoting compounds are ineffective. 
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